At-home psychedelic medicine, minus the ‘trip’

Zalsupindole is an analogue of 5-MeO-DMT, a psychedelic drug derived from desert toad secretions. The company reported a ...
Science Daily

At-home brain stimulation for depression is safe and effective, according to researchers

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...
STAT

Psychedelic-like therapy posts encouraging early data, as regulators clear at-home testing

A psychedelic-like therapy posted encouraging early data, as regulators cleared the drug — not a hallucinogenic — for at-home ...
Psychology TodayOpinion

New Study Raises Questions About Ketamine for Depression

An important study published in JAMA Psychiatry (2025) challenges some of the most popular narratives about ketamine ’s ...
Hosted on MSN

Depressed? New ‘video game’-like technology can help — without drugs or talk therapy

A futuristic fix for depression is here — and it doesn’t involve prescription drugs or a shrink. The first-of-its-kind solution from GrayMatters Health uses something called “self-neuromodulation” to ...
Healthline

Home Essentials for Anxiety and Depression

Depression and anxiety are common in the U.S. Managing anxiety and depression takes daily work, and small additions or changes to your living spaces and routine may help, but they won’t replace ...
The Conversation

Electrical currents delivered to the brain at home may lead to significant reductions in depression symptoms – new research

Amanda Ellison does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Business Wire

LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the preliminary results for the unipolar patient cohort of the RECOVER clinical study ...